Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 12/20 | 0.69 |
| ▸ | THRA | P10827 | 11/20 | 0.69 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.68 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TGM2 | P21980 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20370593 | 0.94 | THRB (0.62) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL20370473 | 0.94 | THRB (0.62) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL20370416 | 0.94 | THRB (0.62) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL19854530 | 0.90 | ZDHHC20 (0.59) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL19856026 | 0.88 | THRB (0.62) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL28482309 | 0.88 | THRB (0.60) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL10363871 | 0.87 | ZDHHC20 (0.58) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL19854544 | 0.86 | THRA (0.51) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL19854605 | 0.86 | THRB (0.53) | THRBTHRAZDHHC20ZDHHC2MEN1 | |
| SCHEMBL19854983 | 0.85 | ZDHHC20 (0.52) | THRBTHRAZDHHC20ZDHHC2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-10662379-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
| US-20180195005-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20180195005-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-07-12 | — | — | US | disclosed |
| WO-2018025974-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE | JNC株式会社 | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180195005-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, MBD2, PAXBP1 | THRB 3939/4885THRA 3929/4885ZDHHC20 946/4885 |
| US-10662379-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | SP1, MBD2, PAXBP1 | THRB 3939/4885THRA 3929/4885ZDHHC20 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.